WallStreetZenWallStreetZen

NYSEMKT: CANF
Can Fite Biopharma Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Can Fite Biopharma earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CANF earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CANF reported annual earnings of -$9.8M, with 24.7% growth.

CANF earnings history

Current Revenue
$405.0k
Current Earnings
$0.0
Current Profit Margin
0%

CANF Return on Equity

Current Company
N/A
Current Industry
-13.6%
Current Market
30.9%

CANF Return on Assets

Current Company
N/A
Current Industry
-10.3%

Be the first to know when CANF announces earnings.

CANF Return on Capital Employed

Current Company
0%
Current Industry
-7%

CANF vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CANFN/AN/AN/AN/A
LABTN/A-$7.35MN/A-$11.35
LIMN-$12.45M-$12.52MN/A-$23.50
DRMA-$8.37M-$8.37MN/A-$4.39
PMCB-$16.15M-$20.63MN/A-$2.31
View Top Biotech Stocks

Can Fite Biopharma Earnings Reports & History FAQ

What were Can Fite Biopharma's earnings last quarter?

Can Fite Biopharma (NYSEMKT: CANF) reported Q2 2026 earnings per share (EPS) of N/A, up N/A year over year. Total CANF earnings for the quarter were N/A. In the same quarter last year, Can Fite Biopharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

Is Can Fite Biopharma profitable or losing money?

As of the last Can Fite Biopharma earnings report, Can Fite Biopharma is currently losing money. Can Fite Biopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.

What was CANF's earnings growth in the past year?

As of Can Fite Biopharma's earnings date in Q3 2026, Can Fite Biopharma's earnings has grown year over year. CANF earnings in the past year totalled N/A.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.